- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Respectful maternity care; health around the world; phony antiobesity medications – Morning Medical Update
The top news stories in primary care today.
© everythingpossible - stock.adobe.com
“Respectful maternity care” sounds like it should be fundamental to medicine. But what exactly is it? Physicians have created frameworks for it, but definitions vary. A new report by the American College of Physicians and the U.S. Agency for Healthcare Research and Quality examines the literature and drafts a definition and approach to care “through a rights- and reproductive justice-based framework.”
American efforts for health abroad
“Investing in global health security today to avert the next global pandemic could save trillions of dollars and millions of lives,” said President Joe Biden’s official statement about a new report that details how the United States is investing in health around the world. For fiscal year 2022, there were 25 partner countries, including war-torn Ukraine.
Phony meds could put patients at risk
The antiobesity drug Ozempic (semaglutide) has prompted a flurry of attention for potential health effects. But the U.S. Food and Drug Administration is warning physicians, pharmacists and patients to watch out for counterfeit versions because little is known about the bogus product’s identity, quality or safety.
